Mark A. Goldsmith files SEC Form 4 disclosures for Revolution Medicines, Inc.. They have made 18 open-market trades across 2 companies since 2020, most recently 2026-09-16.
CIK 0001246842
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 18 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RVMD | 253,342 | $45.1M |
| CNST | 14,987 | $509K |
| Total | $45.6M |
Shares reported on the most recent Form 4, priced at the 2026-09-18 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RVMD | SELL · 10b5-1 | 2026-09-16 | 2026-09-18 | $199.24 | $2.8M | +6.8% | — | — |
| RVMD | SELL · 10b5-1 | 2026-08-21 | 2026-08-25 | $209.20 | $18.0M | +0.3% | -4.6% | — |
| RVMD | SELL · 10b5-1 | 2026-06-16 | 2026-06-18 | $156.12 | $1.6M | +15.5% | +11.1% | +20.8% |
| RVMD | SELL · 10b5-1 | 2026-04-15 | 2026-04-17 | $150.09 | $18.0M | -7.4% | -5.0% | +18.0% |
| RVMD | SELL · 10b5-1 | 2026-03-17 | 2026-03-19 | $99.48 | $2.6M | -0.7% | +49.3% | +61.1% |
| RVMD | SELL | 2026-03-02 | 2026-03-03 | $101.23 | $3.6M | -6.4% | -2.2% | +61.8% |
| RVMD | SELL · 10b5-1 | 2025-12-16 | 2025-12-18 | $76.82 | $2.4M | +2.7% | +49.8% | +26.5% |
| RVMD | SELL · 10b5-1 | 2025-11-25 | 2025-11-26 | $75.08 | $4.7M | +0.2% | +4.0% | +35.0% |
| RVMD | SELL · 10b5-1 | 2025-11-18 | 2025-11-20 | $70.38 | $1.4M | +10.9% | +15.0% | +42.4% |
| RVMD | SELL · 10b5-1 | 2025-11-12 | 2025-11-14 | $65.07 | $2.6M | +14.7% | +16.8% | +43.9% |
| RVMD | SELL · 10b5-1 | 2025-11-07 | 2025-11-12 | $60.31 | $1.8M | +12.4% | +20.4% | +46.5% |
| RVMD | SELL · 10b5-1 | 2025-10-16 | 2025-10-20 | $52.74 | $1.1M | +7.5% | +28.8% | +112.2% |
| RVMD | SELL · 10b5-1 | 2025-09-16 | 2025-09-18 | $45.82 | $1.2M | +2.6% | +18.7% | +68.6% |
| RVMD | SELL · 10b5-1 | 2025-06-16 | 2025-06-18 | $39.83 | $1.1M | -7.8% | -4.2% | +11.8% |
| RVMD | SELL · 10b5-1 | 2025-03-17 | 2025-03-19 | $39.04 | $917K | -7.4% | -4.2% | +2.5% |
| RVMD | SELL · 10b5-1 | 2024-12-16 | 2024-12-18 | $45.40 | $1.1M | +1.0% | -7.0% | -11.9% |
| RVMD | SELL · 10b5-1 | 2024-11-01 | 2024-11-05 | $55.41 | $3.9M | -8.1% | -21.1% | -29.7% |
| RVMD | SELL · 10b5-1 | 2024-10-11 | 2024-10-15 | $50.36 | $1.5M | -5.3% | +17.1% | -13.1% |
| RVMD | SELL · 10b5-1 | 2024-10-01 | 2024-10-03 | $44.93 | $899K | +5.4% | +20.2% | -5.4% |
| RVMD | SELL · 10b5-1 | 2024-09-16 | 2024-09-18 | $44.19 | $1.0M | -0.2% | +11.0% | -0.6% |
| RVMD | SELL · 10b5-1 | 2024-08-01 | 2024-08-02 | $45.88 | $918K | +2.9% | +0.4% | +29.2% |
| RVMD | SELL · 10b5-1 | 2024-07-12 | 2024-07-16 | $45.04 | $1.4M | +0.9% | -5.4% | +7.0% |
| RVMD | SELL · 10b5-1 | 2024-06-17 | 2024-06-20 | $37.39 | $894K | -0.6% | +27.5% | +17.2% |
| RVMD | SELL · 10b5-1 | 2024-06-03 | 2024-06-05 | $39.99 | $528K | -8.1% | -7.0% | +3.0% |
| RVMD | SELL · 10b5-1 | 2024-04-10 | 2024-04-12 | $35.38 | $796K | -1.1% | +3.3% | +20.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.